North East Onco Care Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
- Paid Up Capital ₹ 8.37 Cr
- Company Age 21 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.88 Cr
- Satisfied Charges ₹ 11.45 Cr
- Revenue Growth -8.31%
- Profit Growth -56.68%
- Ebitda -58.78%
- Net Worth 26.54%
- Total Assets 4.94%
About North East Onco Care
North East Onco Care Limited (NEOCL) is a leading Public Limited Indian Non-Government Company incorporated in India on 28 October 2003 and has a history of 21 years and three months. Its registered office is in Kamrup, Assam, India.
The Corporate was formerly known as North East Onco Care Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 8.37 Cr.
The company currently has active open charges totaling ₹21.88 Cr. The company has closed loans amounting to ₹11.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at North East Onco Care Limited India is Pooja Sharma as COMPANY SECRETARY. Ganesh Tamuli, Munindra Baruah, Rajjyoti Changkakoty, and Six other members serve as directors at the Company.
Company Details
- Location
Kamrup, Assam, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110AS2003PLC007246
- Company No.
007246
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
28 Oct 2003
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at North East Onco Care?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Munindra Baruah ![]() | Managing Director | 28-Oct-2003 | Current |
Pooja Sharma | Company Secretary | 01-Jul-2019 | Current |
Board Members (8)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rohan Baruah ![]() | Director | 18-Sep-2020 | Current |
Rajjyoti Changkakoty ![]() | Director | 03-Nov-2020 | Current |
Ganesh Tamuli ![]() | Whole-Time Director | 28-Oct-2003 | Current |
Shakuntala Mahanta ![]() | Director | 13-Mar-2023 | Current |
Jumi Borgohain ![]() | Additional Director | 22-Mar-2024 | Current |
Taanishi Inam ![]() | Whole-Time Director | 07-Dec-2009 | Current |
Financial Performance of North East Onco Care.
North East Onco Care Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.31% decrease. The company also saw a substantial fall in profitability, with a 56.68% decrease in profit. The company's net worth Soared by an impressive increase of 26.54%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of North East Onco Care?
In 2022, North East Onco Care had a promoter holding of 69.15% and a public holding of 30.85%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹21.88 Cr
₹11.45 Cr
Charges Breakdown by Lending Institutions
- Canara Bank : 21.23 Cr
- Axis Bank Limited : 0.65 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
23 Sep 2024 | Axis Bank Limited | ₹1.85 M | Open |
02 Apr 2024 | Axis Bank Limited | ₹4.68 M | Open |
07 Nov 2023 | Canara Bank | ₹1.00 M | Open |
18 Jul 2023 | Canara Bank | ₹1.50 Cr | Open |
09 Aug 2022 | Canara Bank | ₹2.40 Cr | Open |
How Many Employees Work at North East Onco Care?
Unlock and access historical data on people associated with North East Onco Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of North East Onco Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped North East Onco Care's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.